
AI Tools Speed Drug Candidate Screening for Pharma
Boltz's $110 million raise funds growth of pay-per-use molecule and protein design models already used by six of the 20 largest drugmakers.
Live Poll
Do you think AI will make new medicines faster and cheaper for ordinary people?